Novel antidepressants: problems in evaluation.
In conclusion, it is obvious that the program of clinical testing of new antidepressants is a formidable one, taking several years to complete. However, by incorporating careful classificatory, pharmacokinetic, and pharmacodynamic data we should increase our knowledge of the usage of antidepressants generally, as well as the particular novel antidepressant under investigation.